Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02770066

A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension

A Prospective Danish National Registry of Percutaneous Transluminal Renal Angioplasty in Patients With Renovascular Hypertension

Status
Recruiting
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A prospective Danish national registry of percutaneous transluminal renal angioplasty (PTRA) in high-risk patients with renal artery stenosis selected on the basis of common national criteria, and with a common follow-up protocol for all three Danish centres offering PTRA

Conditions

Interventions

TypeNameDescription
DEVICEPercutaneous transluminal renal angioplastyAngioplasty plus stenting (angioplasty in patients with fibromuscular dysplasia) Adjuvant therapy in atherosclerotic renal artery stenosis - at the discretion of the treating physician * Antiplatelet therapy (usually standard) * Cholesterol-lowering drugs (usually standard) * Antihypertensive treatment with angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker (normally not contraindicated) * Smoking cessation, diet and physical activity (usually standard)

Timeline

Start date
2015-01-01
Primary completion
2030-01-01
Completion
2035-01-01
First posted
2016-05-12
Last updated
2025-12-18

Locations

5 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02770066. Inclusion in this directory is not an endorsement.

A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension (NCT02770066) · Clinical Trials Directory